14 October 2022

A CHANCE for researchers to win a registration for the EASL Congress 2023

We are close to reaching 500 patients and we would like to celebrate this milestone with all our colleagues and collaborators in the CHANCE study.

07 October 2022

Our statement on the passing of Ignacio Calero, member of our Board of Trustees

On behalf of our staff, members of our Board of Trustees, and all our colleagues and collaborators, we offer our condolences to Ignacio Calero's family at this time of sadness.

01 October 2022

European Day of Donors and Foundations — Solidarity, Unity, Impact

On 1 October, we wanted to reflect on the theme for the European Day of Donors and Foundations 2022 – Solidarity, Unity, Impact.

30 September 2022

Looking ahead after ACLARA

Connecting and strengthening relationships with the Latin American hepatology community is one of our strategic priorities. The ACLARA study set the framework to conduct large-scale investigations in Latin America and opened the possibility to establish future collaboration with tertiary care centers and university hospitals across the region.

30 September 2022

New collaborative research describes the lack of consensus among European transplant centers in the clinical management of patients with ACLF-3

The results from this retrospective study highlight the inequity of access to intensive care unit, waitlisting, and liver transplantation for patients with acute-on-chronic liver failure grade 3 (ACLF-3) in 20 centers from 8 European countries.

15 September 2022

COBALT completes patient recruitment

The COBALT study will provide evidence of the protective effect of coronavirus disease (COVID-19) vaccination in patients with chronic liver disease and help issue recommendations for future vaccination programs.

14 September 2022

A new EASL position paper reviews currently known liver-specific effects of COVID-19 and provides guidance on the care of adult liver patients

12 September 2022

Reframing our brand

It may be just a subtle change what you may have noticed, but for us at the European Foundation for the Study of Chronic Liver Failure represents a great improvement. Some fresh changes may be noticeable: the update of our logo which now displays new fonts and expansion of our color palette for a range of applications.

26 June 2022

New center in Europe elected member of the EASL-CLIF Consortium

The new member of the EASL-CLIF Consortium joins a network of more than 100 university hospitals and tertiary medical centers in Europe.

25 June 2022

The 2nd CHANCE Investigator Meeting brings together investigators around the globe to share their insights on project progress

The 2nd CHANCE Investigator Meeting took place on 24 June 2022 in London, UK.